Progyny Inc (NAS:PGNY)
$ 23.261 0.35 (1.53%) Market Cap: 2.10 Bil Enterprise Value: 1.82 Bil PE Ratio: 36.30 PB Ratio: 4.55 GF Score: 80/100

Progyny Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2022 / 02:30PM GMT
Release Date Price: $30.17 (-0.69%)
Glen Joseph Santangelo
Jefferies LLC, Research Division - Equity Analyst

All right. Good morning, everyone. Thanks for joining us at the Jefferies conference. It's great to be back in person.

For our next presentation, we're obviously very excited to have the management team from Progyny here with us. To my right is Pete Anevski, who's the CEO of the company; and his right is Mark Livingston, the CFO of the company; and there in the third row is James Hart, who heads the Investor Relations function for the company, who I think maybe most of you know from dealing with him.

All right. Our presentation is going to be 25 minutes. It's going to be a fireside chat. Hopefully, we'll leave some time for maybe a question or two from the audience at the end if we have some time. So in the interest of time, why don't we just get started?

I thought we'd start the presentation with just one general question before kind of going into some of the specific issues just in case there are some people that are new to the story. I want to ask Pete, maybe to just give a quick business model

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot